SAB Bio’s Safeguard Study: A New Way to Approach Type 1 Diabetes Delay and Prevention
What’s next in the attempt to change the course of type 1 diabetes? SAB Bio says they’re looking to redefine what it means to get a type 1 diabetes diagnosis. They’re trialing a drug right now preserve the patient’s ability to make their own insulin.. and maybe even allow repeat dosing. I’m talking to Dr.…